Motus GI (MOTS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock MOTS vs. NMRD, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, and LUCYWShould you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry. Motus GI vs. Its Competitors Nemaura Medical Minerva Surgical Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Nemaura Medical (NASDAQ:NMRD) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations. Is NMRD or MOTS more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Motus GI N/A N/A N/A Which has higher earnings and valuation, NMRD or MOTS? Motus GI has higher revenue and earnings than Nemaura Medical. Nemaura Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K1.34-$14.14M-$0.390.00Motus GI$319K0.00-$12.87M-$15.64N/A Does the media prefer NMRD or MOTS? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Motus GI Neutral Do insiders & institutionals hold more shares of NMRD or MOTS? 4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, NMRD or MOTS? Nemaura Medical has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. SummaryMotus GI beats Nemaura Medical on 5 of the 7 factors compared between the two stocks. Get Motus GI News Delivered to You Automatically Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MOTS vs. The Competition Export to ExcelMetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$71.71M$5.72B$10.40BDividend YieldN/AN/A5.53%4.58%P/E Ratio0.0011.0076.4326.62Price / SalesN/A35.67472.7192.34Price / CashN/A18.4137.4661.85Price / BookN/A15.1313.276.45Net Income-$12.87M-$25.86M$3.29B$271.39M Motus GI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MOTSMotus GI0.0303 of 5 starsN/AN/AN/A$1K$319K0.0030NMRDNemaura Medical0.7132 of 5 stars$0.00flatN/A-99.3%$4K$3.02K0.0040Upcoming EarningsUTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160VIVEViveve MedicalN/AN/AN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.30+3.2%N/A+79.0%$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.04+0.2%N/A-52.8%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.01-19.4%N/A-57.0%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$10.39-3.7%N/A-82.8%$0.00N/A0.002Gap DownHSCSWHeart Test LaboratoriesN/A$0.09+19.3%N/A+170.4%$0.00$4.35K0.0010Gap UpBEATWHeartBeamN/A$0.24+3.9%N/A-39.8%$0.00N/A0.005News CoverageGap DownLUCYWInnovative EyewearN/A$0.10+8.9%N/A+65.9%$0.00$1.98M0.009Gap Up Related Companies and Tools Related Companies NMRD Alternatives UTRS Alternatives VIVE Alternatives DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MOTS) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MOTS Stock Alerts